Exploring the proposed changes to NICE’s approach to health technology assessment
Meet the best of the best in 2021
Transforming Beyond the Pill from optional industry extra to essential market opportunity
What makes trade secrets different from other types of IP protection?
Why it is crucial to invest in the progress of the clinical research workforce
Responding to the explosion of mobile & digital health across international markets
How can the healthcare industry communicate with Gen Z adolescents?
PharmaTimes talks to argenx’s Vice President, Head of Medical Affairs and country manager, UK and Ireland
42.
Appointments